Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · IEX Real-Time Price · USD
2.720
-0.050 (-1.81%)
At close: Jul 19, 2024, 4:00 PM
2.740
+0.020 (0.74%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $118.20 million as of July 22, 2024. Its market cap has increased by 4.42% in one year.
Market Cap
118.20M
Enterprise Value
30.28M
1-Year Change
4.42%
Ranking
Category
Stock Price
$2.72
Market Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $118.20M, a decrease of -73.16%. That is a compound annual growth rate of -33.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 118.20M | -15.39% |
| Dec 29, 2023 | 139.70M | 121.75% |
| Dec 30, 2022 | 63.00M | -80.82% |
| Dec 31, 2021 | 328.50M | -25.41% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annovis Bio | 126.57M |
| Agenus | 125.79M |
| Relmada Therapeutics | 125.52M |
| Nuvectis Pharma | 123.35M |
| Athira Pharma | 119.20M |
| Seer, Inc. | 116.89M |
| Akoya Biosciences | 116.55M |
| American Well | 116.21M |